LILRB4 and acute myeloid leukemia: reported that forced expression of FTO contributed to the elevated expression of immune checkpoint genes such as PD-L1, PD-L2, and leukocyte immunoglobulin-like receptor subfamily B4 (LILRB4) via inhibiting YTHDF2-dependent degradation in AML cell lines (44).